Hirudin

From WikiMD's WELLNESSPEDIA

(Redirected from Desirudin)


Overview[edit]

Hirudin in complex with thrombin

Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (Hirudo medicinalis). It is known for its potent anticoagulant properties, which it exerts by inhibiting thrombin, a key enzyme in the coagulation cascade. Hirudin is one of the most effective natural inhibitors of thrombin, making it a valuable tool in both medical and research settings.

Structure and Function[edit]

Hirudin is a small protein consisting of 65 amino acids. It binds to thrombin with high affinity, blocking its active site and preventing the conversion of fibrinogen to fibrin, a crucial step in blood clot formation. This action effectively prevents the formation of blood clots, making hirudin a powerful anticoagulant.

The structure of hirudin allows it to bind tightly to thrombin, forming a stable complex. This interaction is depicted in the image to the right, showing hirudin in complex with thrombin. The binding of hirudin to thrombin is irreversible, which distinguishes it from other anticoagulants that act as competitive inhibitors.

Medical Applications[edit]

Hirudin and its derivatives have been used in various medical applications, particularly in conditions where anticoagulation is necessary. It is used in the treatment of deep vein thrombosis, pulmonary embolism, and during certain surgical procedures to prevent clot formation. Hirudin is also used in patients who have developed heparin-induced thrombocytopenia, as it provides an alternative anticoagulant therapy.

Synthetic Derivatives[edit]

Due to the limited availability of natural hirudin, synthetic derivatives have been developed. These include lepirudin, desirudin, and bivalirudin, which are used in clinical settings. These synthetic forms retain the anticoagulant properties of natural hirudin but are produced through recombinant DNA technology, allowing for greater availability and consistency.

Mechanism of Action[edit]

Hirudin exerts its anticoagulant effect by directly inhibiting thrombin. Unlike other anticoagulants such as warfarin or heparin, hirudin does not require a cofactor to exert its effect. It binds directly to thrombin, blocking its enzymatic activity and preventing the conversion of fibrinogen to fibrin. This direct inhibition makes hirudin a highly effective anticoagulant, particularly in situations where rapid anticoagulation is required.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.